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DDD Pacing Mode Survival in Patients With a Dual-Chamber Pacemaker
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CAROLYN ANDREWS, PA-C, SEYMOUR FURMAN, MD, FACC
Bronx, New York
Dual-chamber (DDD) pacing mode survival was assessed by
reviewing 486 consecutive initial transvenous DDD pacemaker
implantation between December 1981 and December 1988 inclu-
sive, with a mean follow-up time of 33 months . The patients' mean
age was 71.4 years and 55% were male; 38% had dominant
siooalrial and 62% had dominant atrioventricular (AV) node
disease. Nineteen patients (4%) underwent secondary operative
intervention for lead dislodgment (n =11), lead or pulse generator
malfunction (n = 6) or infection (n = 2) .
During follow-up, 87 patients (18%) had their device perma-
nently reprogrammed out of the DDD mode and 10 others (2%)
required temporary reprogramming out of this mode ; 12 patients
who required device reprogramming were managed in other
dual-chamber or atria) pacing modes. Reasons for reprogram-
ming included atria) fibrillation (n = 48; 10%); loss of atria)
sensing (n = 26 ; 5%) ; recurrent "endless loop" tachycardia (n =
The DDD mode of dual-chamber cardiac pacing provides for
sensing and pacing capabilities in both the atrium and
ventricle, and for coordinated activity between the cham-
bers. The ventricular-inhibited (VVI) mode senses and paces
the ventricle exclusively, thus precluding maintenance of
atrieventricular (AV) synchrony . The hemadynamic advan-
tages of DDD pacing over those of single-rate ventricular
systems are well known, and evidence exists suggesting
improved patient survival (1) when AV synchrony is main-
ained . The complexity of implantation and follow-up of
these systems is also well appreciated, with problems arising
that may necessitate programming out of the DDD mode.
Only limited data are available addressing the long-term
maintenance of the DDD mode . This issue is particularly
important because rate-modulated ventricular systems now
available offer some of the same advantages of dual-chamber
systems without some of the potential difficulties. We re-
viewed our experience with DOD pacemaker implantation
and long-term follow-up in order to address the incidence
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5;1 %) ; lead dislodgment without repositioning (n = 4;1%) ; pulse
generator malfunction (n = 1 ; 1%) and other (a = 5 ; 1%) .
The occurrence of trivial fibrillation was associated with dom .
inant sinomrial disease and a prior history of
atrial fibrillation;
19% of atrial sensing loss was attributable to early or faulty
pacemaker technology. The DDD mode survival rate at 1, 2, 3, 4
and 5 years was, respectively, 90%, 88%, 84%, 79% and 78% .
It is concluded that 1) 4% of DDD pacemaker implants
required secondary surgical intervention; 2) 82% of implanted
pacemakers remained In the DDD mode throughout follow-up ;
3) onset of atria) fibrillation or loss of atria) sensing accounted for
73% of the mode changes; 4)10% of the permanent mode changes
were directly related to early or defective pacemaker technology;
and 5) DDD pacing remains a very reliable and effective long-tan
therapy in the majority of patients with a DDD Pacemaker.
(J Am Cog Cordial 1992 ;19,1536-41)
and reasons for abandonment of the DDD mode and to
evaluate the long-term efficacy of DOD pacing .
Methods
Study patients
. We reviewed 486 consecutive initial
transvenous implantations of DDD pacemakers at our insti-
tution from December 1981 until December 1988 . Revisions,
upgrades, thoracotomy implantations and dual-chamber sys-
tems that did not include the DDD pacing option were
excluded . All patients were in a rhythm amenable to DDD
pacing at the time of pacemaker implantation . Patients were
followed up with routine pacemaker evaluations until death,
loss to follow-up or until September 1989, allowing for a
potential minimum of 9 months of data collection after
pacemaker implantation.
Demographic information reviewed included patient age
and gender, indication for implantation (dominant sineatrial
ISA] vs . atrioventricular [AV] conduction disease) and pres-
ence or absence of a history of atria) fibrillation .
Implantation data. The following information recorded at
the time of implantation was analyzed for the purpose of this
review: 1) pulse generator model ; 2) lead model ; 3) atrial and
ventricular signal amplitudes and slew rates
; 4) atria] and
ventricular pacing thresholds at 0 .5 ms in volts ; and
5) presence of retrograde conduction .
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Follow-up data. The following information was obtained
during routine follow-up at our pacemaker center : 1) dura-
tion of follow-up
; 2) need for a secondary reparative opera-
tive procedure; 3) need for reprogramming out of the DDD
mode and duration of the various modes ; and 4) reason for
reprogramming including the development of atrial fibrilla-
tion, loss of atral sensing or pacing, recurrent endless loop
tachycardia, diaphragmatic stimulation, pulse generator mat-
function and lead dislodgment without repositioning .
In evaluating these data, we specifically identified those
pulse generators considered to be "early generation" with
atria) sensing limited to 0.75 mV or atrial refractory periods
that were either nonprogrammable or restricted to a maxi-
mum of 250 ms. Those units include models 7000 and 7000A
(Medtronic) and model 2251 (Telectronics Pacing Systems) .
We also identified those atria) leads now known to be
associated with early deterioration : Medtronic model 6991 U .
Statistical analysis. A cumulative DDD pacing mode sur-
vival curve was calculated by the Kaplan-Meer method . A
pacemaker was defined as a nonsurvivor if it was pro-
grammed out of the DDD mode for the remainder of the
patient's follow-up . Comparative data were analyzed by
using a chi-square or two-tailed 1-test. Where appropriate,
values are expressed as mean values ± SD
.
Results
Clinical data . Patient age was 71 .4 ± 13.5 years; 267
(55%) were male, 187 (38%) had predominant sinus node
disease and 299 (62%) had predominant AV conduction
disease; 38 (7.8%) had a history of atrial fibrillation on at
least one occasion before pacemaker implantation . The
mean follow-up interval was 33 months .
Pacemaker data. During initial pacemaker implantation
the following data were obtained . The mean atrial amplitude
was 3.95 ± 2 .07 mV, the mean slew rate 2.48 ± 1 .88 mV/s
and the mean atria) pacing threshold 0 .76 ± 0.36 V at a pulse
duration of 0 .5 ms. The mean ventricular amplitude was
11 .48 ± 5.33 mV, the mean slew rate 5 .37 ± 3 .44 mV/s and
the mean pacing threshold 0.41 ± 0.14 V at a pulse duration
of 0 .5 ms . Retrograde conduction was present at one or more
ventricular paced rates in 188 patients (38 .6%). The pace-
maker and lead models utilized are listed in Tables I and 2,
respectively.
Secondary Interventions. A total of 19 patients (4%) re-
quired a secondary operative procedure
. Lead repositioning
after dislodgment was required in I I patients (2%) (atrial in
6, ventricular in 3 and both atrial and ventricular in 2) . Two
patients required lead replacement after lead fracture ; two
had a pacemaker infection and four had pulse generator
failure. Pulse generator replacement for normal battery
depletion was not considered a reparative intervention .
Pacemaker survival In the DDD made. Ninety-seven pa-
tients (20%) required at least temporary programming of
their device out of the DDD mode, and 87 (17.9%) required
programming out of the DDD mode to the end of their
Table 1 . Pulse Gero:rators Implanted
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'Pulse generators with United
programmability.
follow-up . After 6 months of follow-up . 91 .6% of pacemak-
ers were still in the DDD mode ; at 12 months 89.8%. at IS
months 89
.1%, at 24 months 87 .6%, at 36 month. 23 .9%, at
48 months 79.3% and at 60 months 77.9% of pacemakers
were sun in the DUD mo :c . :igum i snows a sarioal curve
displaying cumulative pacemaker survival in the DDD mode .
Reasons for reprogramming (Fig . 2). The most common
reason for reprogramming out of the DDD mode was the
development of atrial fibrillation, noted in 48 patients (9 .9%).
Of these 48 patients, II had a return of sinus rhythm and
pacing in the DDD mode was restored at least temporarily .
Although six patients again developed atrial fibrillation, they
remained in sinus rhythm and the pacemaker remained in the
DDD mode for a mean of 24 months.
Twenty-six patients (5.3%) had their device programmed
out of the DDD mode because of loss of atral sensing. Three
of these patients had a failed atrial lead and four had
an early
generation pacemaker with limited atria] sensing capabili-
ties .
Five patients (1%) had a recurrent endless loop tachycar-
dia. In two of these patients the pacing unit had limited atrial
refractory period programmability, in two the unit was
suspected of tracking concomitant supraventricuhr tachy-
cardias, and in one patient reprogramming to atria) inhibited
(AAI) mode proved effective. Pacemaker reprogramming
was performed in five patients (1%) because of diaphrag-
matic stimulation (due to the ventricular lead in one), loss of
atrial capture in five (1%), lead dislodgment without reposi-
Model
No. tmplnated
233D
U
233E 64
2336 7
23317L
12
233GR 6
2406 19
283 -3
283-01 55
284-02 3
415A 63
418A 27
674 13
925 25
926 2
2020T 1
2251' 22
2291
17
Won'
10
73MA' 11
7005 25
7006 24
7070 1
7071 1
501 13
505 9
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Table 2 . Pacemaker Leads Implanted
SV-101 2
"Atria] lead with a high failure rate .
tioning in four(]%), pulse generator malfunction in the DDD
mode only in one, and miscellaneous reasons in five (1%) .
Subgroup Analysis
Loss of atria) sensing . Among the 26 patients whose
pacemaker lost aerial sensing, 3 patients had an atria] lead
that was later found to have a high incidence of failure .Two
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Figure 2. All causes of pacing mode change, temporary and perma-
nent, and their relative frequency of occurrence .
of these threa patients also had an early generation pace-
maker wit- limited atria) sensing capabilities . An additional
two patients whose units lost atria) sensing had an early
generation unit.
In 8 of the remaining 21 patients, their pacemaker lost
aerial sensing exclusively during the pen-implantation period
and their device was programmed back to the
DDD mode a
mean of 2.5 months after implantation. Four of these pa-
tier4s later required device reprogramming out of the DDD
mode for other reasons; one patient developed aired fibril-
lation, another had poorly tolerated sinus tachycardia at rest
and two developed diaphragmatic stimulation. Only 13 pa-
tients (2 .7%) required permanent abandonment of the DDD
pacing mode because of loss of atria) sensing not attributable
to early generation pacemaker technology.
In the 21 patients whose pacing unit lost atria) sensing
independent of hardware limitations, the mean aerial ampli-
tude and slew rate were 3 .40 ± 1 .13 mV and 1 .72 ±
1 .07 mV/s, respectively . These values were not statistically
different from those in the remaining 465 patients . In the 13
patients whose units permanently lost atria) sensing, the
mean amplitude and slew rate were 3 .33 ± 1 .23 mV and 1 .61
0 .77 mV/s, respectively (p = NS).
Figure 1. Cumulative survival of the DDD pacing mode by
Kaplan-Meier analysis . The number of patients exposed at
each interval is shown.
Atnal Leads Ventricular Leads
Model No . Implanted Model
No .lmplented
321-IOIP
2 327-152 82
327-745 17
327-162 1
327-752
64 327-252 1
328-752 5 328-158A 1
329400P 2 328-162 4
329-101P 3 329-158
152
329-258 1
329-158A 71
329-740
1 329.158P II
329-748 132 329-159 3
329-748A
54 329-159P I
329-748P 61
329-258 39
329-759 38
329-749
1
480-01 2 480-01 1
467-01 6 484-1 1
492-01 1 486-01 2
1012T 1
493-03 1
4266 495-01
5
4270 9 1016T 1
4511 13 4011
Is
4512
22 4012 24
6957J
14 4260 7
6091U' 23 4266 2
6993 12 6957 9
4512-53 1 6971 37
SJ-103 I AV-102 12
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Table 3
. Comparison of the Clinical Characteristics of Patients
Who Did and Did Not Develop Atria) Fibrillation
AF = goal fih llation ; Pts = patients ; SA = sinoalrial: VA conduction =
intact retrograde conduction .
AteiJ fibrillation. Forty-eigat patients (10%) developed
atrial fibrillation requiring at least temporary reprogramming
of their unit to the VVI mode . Variables at implantation
thought to promote the future development of atria) fibrilla-
tion were analyzed, including age, gender, indication for
implantation (primary SA vs . AV node disease), history of
atrial fibrillation, atria) electrogram amplitude, slew rate,
stimulation threshold and the presence of retrograde conduc-
tion. These features were compared in the groups that did
and did not develop atria) fibrillation (Table
3). There was a
substantially greater prevalence of SA node disease (69% vs
.
35%) and history of atria) fibrillation (29%
vs . 5%) in the
group that developed atrial fibrillation (p < 0.001). The mean
age of this group was 75 ± 8.4 years versus 71 ± 13
.9 years
in the group without atria) fibrillation and this difference
reached statistical significance (p = 0.63). Differences be-
tween the two groups in atrial electrogram amplitudes, slew
rates and thresholds as well as the incidence of retrograde
conduction were not statistically significant .
Discussion
DDD versus VVI pacing modes. The DDD pacing mode
(sensing and pacing in atrium and ventricle) provides im-
proved hemodynamics, exercise capacity and sense
of well-
being (2-5)
when compared with VVI pacing (sensing and
pacing in ventricle only) . Other potential advantages of DDD
pacing include a reduced incidence of aerial arrhythmias (6,7)
and, perhaps, improved patient survival (1). Despite these
considerations, DDD systems are considerably more expen-
sive, have a shorter life span, are more difficult to implant
and require more complex programming than do single-lead
systems. Additionally, all advantages of DDD systems are
lost if reprogramming to the VVI mode becomes necessary .
Atria) lead displacement or failure, loss of atrial sensing or
pacing, recurrent or persistent atria) tachyarhythmia, inap-
propriate interaction between pulse generator channels and
intolerance of faster pacing rates are among the factor that
GROSS ET At ..
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may necessitate reprogramming out of the DDD mode .
Thus, evaluation of DDD pacemaker efficacy requires long-
term assessment of DDD mode life span and analysis of the
reasons for DDD pacing failure .
Previous studies. Data on the long-term efficacy of DDD
pacemakers are quite limited, and two early reports (8,9)
lack many of the details and duration of follow-up necessary
to make this determination . In one study (8) with implanta-
tion and follow-up data on 250 patients, most
of the devices
used were rarly generation devices, the follow-up period
was short and the two most common problems described,
recurrent endless loop tarhycardia and pectoral muscle
stimulation,
occur infrequently with current generation de-
vices
. Similarly, an early
report (10) on patients in our
institution included a much higher proportion of early gen-
eration devices and early operative experience and encom-
passed a much shorter follow up-period than are described in
the present study .
Results of DDD pacing. This study describes the clinical
outcome of a large group of university hospital patients who
underwent DDD pacemaker implantation and tallow-up
dur-
ing a period of almost 8 years . Only 4% of pacemaker
implantations required a secondary operative intervention
and only half of these revisions were attributable
to aerial
lead malfunction or other problems specific to
DDD pacing.
The observed 78% 5-year cumulative rate of DDD mode
pacemaker survival demonstrates that the DOD pacemaker
functions in its intended manner for the entire life of the
device in most patients . These observations indicate that the
incidence of problems associated with DDD pacing systems
(discussed later) is low, and they support the routine use of
these devices in the vast majority of patients with intact
atria) function.
DDD mode loss, a primary end point in this study, does
cot ahean complete loss of dual-chamber function. Although
most pacing mode changes resulted in VVI programming,
14% of the permanent reprogeammings utilized
features of
dual-chamber or atria) pacing . Four patients with atria)
sensing loss were managed in the DVI mode, 5 patients with
loss of aerial capture ordiaphragmatic stimulation underwent
reprogramming to the VDD mode and 3 patients were able to
be paced in the AAI mode
. Another point worth reemphasis
is that 10% of permanent mode changes are attributable to
early pacemaker technology and are irrelevant to patients
now undergoing pacemaker implantation
.
Atria) fdrrimtioa m a cause of DDD pacing mode failure.
This study does not allow determination of the absolute
incidence of specific pacemaker-related problems, only the
frequency of clinical events that necessitated pacing mode
changes. The most common reason for reprogramming
was
the development of aerial fibrillation, occurring in 10% of the
patients. A previous report (9) has also suggested that atria)
fibrillation is the most common reason for mode change
.
To determine which patients were at high risk for the later
development of atria) fibrillation, a number of factors
known
at the time of implantation were examined . The small age
Pin
With
AF
Pis
Without
AF P Value
(n=13) (n=438)
SA disease (no.) 33(699f) 154 (35%) <0.001
History of AF (no.) 14 (29%) 24(57) <0.1n1
Age (yr) 75 m 8.4 71 *- 13 .9
0
.03
Men (no .) 22 (46%) 24506%) 024
Aerial electrogmm
Amplitude (mV) 3
.90 ! 2 .06 3 .94 x 2.37 0.89
Slew rate
(.VA) 2.41 m 1 .87 2 .57
,
2.06 0.58
Artist pacing threshold (V) 0 .67 < 0.27 0.77 = 0.37 0.08
VA conduction (no.) 18(38%) 170(3) 0.35
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Figure 3
.
Schematic represenial,on of atrial fibrillation
(API occur-
rence in this study population . NSR = no, mal sinus rhythm.
difference between the groups with and without atria) fibril-
lation reached statistical significance but the absolute differ-
ence was relatively small and thus patient age itself is
probably not a particularly useful predictor of DDD mode
failure. Patients developing atrial fibrillation had a much
higher incidence of SA node disease and were far more
likely to have had a history of atrial fibrillation, finding
consistent with an earlier report (1). Nevertheless, the
majority of patients with a history of atrial fibrillation (65%)
and SA node disease (83%) remained in sinus rhythm and
received the benefit of DDD pacing throughout their follow-
up . Additionally, nearly 25% of the patients who developed
atrial fibrillation regained sinus rhythm and underwent re-
programming back to the DDD mode for substantial amounts
of time (mean 24 months) (Fig . 3) . Thus, although some
patients are at increased risk for developing atrial fibrillation,
none of the factors analyzed are indicative of likely DDD
mode failure . In fact, these high risk patients in particular
may benefit from DDD pacing . Patients with isolated sinus
node dysfunction have a higher incidence of intact retro-
grade conduction that predisposes them to "pacemaker
syndrome" with pacing in the VVI mode . There are also
data (6) indicating that the incidence of atrial arrhythmia
occurrence is far lower with DOD than with VVI pacing ;
thus the ODD mode should be preferable in these higher risk
patients .
Other causes of DDD pacing mode failure. An acceptable
rate of DDD mode loss occurs in the high risk subsets we
have identified, but other factors not specifical', -
evaluated in
this study, severe mitral valve disease, for example, might
be far more important risk factors for ODD mode failure .
Patients with such disease might be best managed with a
DDD pacemaker a ith rate-modulation capabilities, provid-
ing AV synchrony and a lower risk of arrhythmia occurrence
during sinus rhythm, as well + .s rate-modulated ventricular
pacing in the event of atria) channel failure or development
of atrial fibrillati.n .
JAC'
. Vol . 19, No. 7
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Loss of atria) sensing. This was the second most common
reason for DOD mode loss, and refinement of atria] sensing
and lead technology has reduced but not eliminated the
problem. Although assessment of electrophysiologic (that is,
signal characteristics and pacing threshold) variables is
necessary for intraoperative lead positioning, no variable
measured with the lead in final position predicted later
sensing loss . The limited number of active fixation leads
implanted in this population prevents analysis of the in-
fluence of fixation modality on sensing. Recurrent end-
less loop tachycardia was a very infrequent problem, and
with current technology can almost always be eliminated
while DDD pacing is maintained . The remaining causes
for mode changes were very infrequent and their low inci-
dence precludes detailed analysis of risk factors for their
development .
Limitations. This study is limited by its retrospective
nature
. No definitive comparisons with VVI pacing can be
made given the high likelihood of preselection bias of this
study population . Effects of drug therapy or other patient
factors on DDD efficacy cannot be assessed from this data
base. Despite these limitations, the population size, duration
of follow-up and the random nature of clinical presentation
of the patients all support the position that the data are quite
applicable to the pacemaker population at large .
Conclusions. The clinical use of DDD pacemakers is now
entering its 2nd decade and sufficient experience is available
for the systematic evaluation of the long-term function of
DDD pacing . Our data indicate that the majority of patients
can be managed in a dual-chamber pacing mode throughout
their follow-up . Fewer than 4% of patients required a sec-
ondary operative procedure, and there is nearly an 80%/
5-year survival of the DDD pacemaker mode. Seventy-five
percent of DOD mode loss was due to atrial fibrillation (49%)
or atrial sensing failure (25%) . Atrial fibrillation developed in
a disproportionate number of patients with sinoatrial disease
or a prior history of atrial fibrillation, but the majority of
these higher risk patients could be managed in the DDD
mode throughout much or all of their follow-up .
These data confirm that the majority of patients in
rhythms amenable to dual-chamber pacing at the time of
implantation can be successfully treated with DDD pacing
throughout their course . Patients perceived to be at partic-
ularly high risk for DDD pacing failure or those with chro-
notropic incompetence may be managed with a DDD pace-
maker that has rate-modulation capabilities. Our data
confirm that the DDD pacing mode is highly effective on
both a short- and a long-term basis and new technologic
advances, such as rate modulation, are likely to complement
rather than supplant this mode of therapy.
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